Chest CT features are associated with poorer quality of life in acute lung injury survivors

Critical Care Medicine

Volumn 41, Issue 2, 2013, Pages 445-456

  Burnham, Ellen L ^a   Hyzy, Robert C ^b   Paine, Robert ^c   Coley, Curtis ^b   Kelly, Aine M ^b   Quint, Leslie E ^b   Lynch, David ^d   Janssen, William J ^d   Moss, Marc ^a   Standiford, Theodore J ^b  

^a UNIVERSITY OF COLORADO SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^c UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

^d DEPARTMENT OF MEDICINE   (United States)

Author keywords

biomarker; fibroproliferation; pulmonary function; radiologic; restriction; reticulation

Indexed keywords

CARBON MONOXIDE;

ACUTE LUNG INJURY; ARTICLE; ARTIFICIAL VENTILATION; COHORT ANALYSIS; COMPUTER ASSISTED TOMOGRAPHY; DEMOGRAPHY; FOLLOW UP; HEALTH SURVEY; HUMAN; INTENSIVE CARE UNIT; LUNG CAPACITY; LUNG FUNCTION TEST; POSITIVE END EXPIRATORY PRESSURE; PREDICTION; PRIORITY JOURNAL; PROCESS OPTIMIZATION; QUALITY OF LIFE; QUESTIONNAIRE; RESPIRATORY DISTRESS SYNDROME; RISK FACTOR; SHORT FORM 36;

ACUTE LUNG INJURY; APACHE; FEMALE; FOLLOW-UP STUDIES; HUMANS; INTENSIVE CARE UNITS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; PNEUMONIA; PULMONARY DIFFUSING CAPACITY; QUALITY OF LIFE; SURVIVORS; TOMOGRAPHY, X-RAY COMPUTED; TOTAL LUNG CAPACITY; VITAL CAPACITY;

EID: 84873392146     PISSN: 00903493     EISSN: 15300293     Source Type: Journal    
DOI: 10.1097/CCM.0b013e31826a5062     Document Type: Article

References (34)

1. Matthay MA, Brower RG, Carson S, et al: Randomized, placebo-controlled clinical trial of an aerosolized beta-2 agonist for treatment of acute lung injury. Am. J. Respir. Crit Care Med 2011; 184:561-568
2. Wiedemann H P, Wheeler AP, Bernard GR, et al; National Heart, Lung, and Blood Institute Acute Respiratory Distress Syndrome (ARDS) Clinical Trials Network: Comparison of two fuid-management strategies in acute lung injury. N Engl J Med 2006; 354:2564-2575
3. Herridge MS, Cheung AM, Tansey CM, et al; Canadian Critical Care Trials Group: One-year outcomes in survivors of the acute respiratory distress syndrome. N Engl J Med 2003; 348:683-693
4. Herridge MS, Tansey CM, Matté A, et al; Canadian Critical Care Trials Group: Functional disability 5 years after acute respiratory distress syndrome. N Engl J Med 2011; 364:1293-1304
5. Orme J Jr, Romney JS, Hopkins RO, et al: Pulmonary function and health-related quality of life in survivors of acute respiratory distress syndrome. Am J Respir Crit Care Med 2003; 167:690-694
6. Heyland DK, Groll D, Caeser M: Survivors of acute respiratory distress syndrome: Relationship between pulmonary dysfunction and long-term health-related quality of life. Crit Care Med 2005; 33:1549-1556
7. Masclans JR, Roca O, Muñoz X, et al: Quality of life, pulmonary function, and tomographic scan abnormalities after ARDS. Chest 2011; 139:1340-1346
8. Paine R 3rd, Standiford TJ, Dechert RE, et al: A randomized trial of recombinant human granulocyte-macrophage colony stimulating factor for patients with acute lung injury. Crit Care Med 2012; 40:90-97
9. Bernard GR, Artigas A, Brigham KL, et al: The American-European Consensus Conference on ARDS. Defnitions, mechanisms, relevant outcomes, and clinical trial coordination. Am J Respir Crit Care Med 1994; 149(3 Pt 1):818-824
10. The Acute Respiratory Distress Syndrome Network: Ventilation with lower tidal volumes as compared with traditional tidal volumes for acute lung injury and the acute respiratory distress syndrome. N Engl J Med 2000; 342:1301-1308
11. Crotti S, Mascheroni D, Caironi P, et al: Recruitment and derecruit-ment during acute respiratory failure: A clinical study. Am J Respir Crit Care Med 2001; 164:131-140
12. Desai SR, Wells AU, Rubens MB, et al: Acute respiratory distress syndrome: CT abnormalities at long-term follow-up. Radiology 1999; 210:29-35
13. Ichikado K, Suga M, Muranaka H, et al: Prediction of prognosis for acute respiratory distress syndrome with thin-section CT: Validation in 44 cases. Radiology 2006; 238:321-329
14. Kleyweg R P, van der Meché FG, Schmitz PI: Interobserver agreement in the assessment of muscle strength and functional abilities in Guillain-Barré syndrome. Muscle Nerve 1991; 14:1103-1109
15. De Jonghe B, Sharshar T, Lefaucheur J P, et al; Groupe de Réfexion et d'Etude des Neuromyopathies en Réanimation: Paresis acquired in the intensive care unit: A prospective multicenter study. JAMA 2002; 288:2859-2867
16. Ali NA, O'Brien JM Jr, Hoffmann S P, et al; Midwest Critical Care Consortium: Acquired weakness, handgrip strength, and mortality in critically ill patients. Am J Respir Crit Care Med 2008; 178:261-268
17. Ware JE Jr, Sherbourne CD: The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection. Med Care 1992; 30:473-483
18. Jones PW, Forde Y: St George's Respiratory Questionnaire Manual. St. George's University of London, London, UK, 2008, pp 1-16
19. Davidson TA, Caldwell ES, Curtis JR, et al: Reduced quality of life in survivors of acute respiratory distress syndrome compared with critically ill control patients. JAMA 1999; 281:354-360
20. Pellegrino R, Viegi G, Brusasco V, et al: Interpretative strategies for lung function tests. Eur Respir J 2005; 26:948-968
21. Raghu G, Collard HR, Egan JJ, et al; ATS/ERS/JRS/ALAT Committee on Idiopathic Pulmonary Fibrosis: An offcial ATS/ERS/JRS/ALAT statement: Idiopathic pulmonary fbrosis: Evidence-based guidelines for diagnosis and management. Am J Respir Crit Care Med 2011; 183:788-824
22. Nöbauer-Huhmann IM, Eibenberger K, Schaefer-Prokop C, et al: Changes in lung parenchyma after acute respiratory distress syndrome (ARDS): Assessment with high-resolution computed tomography. Eur Radiol 2001; 11:2436-2443
23. Chesnutt AN, Matthay MA, Tibayan FA, et al: Early detection of type III procollagen peptide in acute lung injury. Pathogenetic and prognostic signifcance. Am J Respir Crit Care Med 1997; 156(3 Pt 1):840-845
24. Clark JG, Milberg JA, Steinberg K P, et al: Type III procollagen peptide in the adult respiratory distress syndrome. Association of increased peptide levels in bronchoalveolar lavage fuid with increased risk for death. Ann Intern Med 1995; 122:17-23
25. Marshall RP, Bellingan G, Webb S, et al: Fibroproliferation occurs early in the acute respiratory distress syndrome and impacts on outcome. Am J Respir Crit Care Med 2000; 162:1783-1788
26. Chesnutt AN, Kheradmand F, Folkesson HG, et al: Soluble transforming growth factor-alpha is present in the pulmonary edema fuid of patients with acute lung injury. Chest 1997; 111:652-656
27. Martin C, Papazian L, Payan MJ, et al: Pulmonary fbrosis correlates with outcome in adult respiratory distress syndrome. A study in mechanically ventilated patients. Chest 1995; 107:196-200
28. Budinger GR, Chandel NS, Donnelly HK, et al: Active transforming growth factor-beta1 activates the procollagen I promoter in patients with acute lung injury. Intensive Care Med 2005; 31:121-128
29. Horowitz JC, Cui Z, Moore TA, et al: Constitutive activation of prosur-vival signaling in alveolar mesenchymal cells isolated from patients with nonresolving acute respiratory distress syndrome. Am J Physiol Lung Cell Mol Physiol 2006; 290:L415-L425
30. Synenki L, Chandel NS, Budinger GR, et al: Bronchoalveolar lavage fuid from patients with acute lung injury/acute respiratory distress syndrome induces myofbroblast differentiation. Crit Care Med 2007; 35: 842-848
31. Quesnel C, Nardelli L, Piednoir P, et al: Alveolar fbroblasts in acute lung injury: Biological behaviour and clinical relevance. Eur Respir J 2010; 35:1312-1321
32. Fan E, Ciesla ND, Truong AD, et al: Inter-rater reliability of manual muscle strength testing in ICU survivors and simulated patients. Intensive Care Med 2010; 36:1038-1043
33. Hough CL, Lieu BK, Caldwell ES: Manual muscle strength testing of critically ill patients: Feasibility and interobserver agreement. Crit Care 2011; 15:R43
34. Khan J, Harrison TB, Rich MM, et al: Early development of critical illness myopathy and neuropathy in patients with severe sepsis. Neurology 2006; 67:1421-1425